APAdrien Le Pluart

Adrien Le Pluart

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Adrien Le Pluart has a total of 27 co-authors. Here are the top co-authors by number of shared publications:

  • Frédéric Blanchard

    Nantes Université, Oniris, CHU Nantes, INSERM, Regenerative Medicine and Skeleton, RMeS, UMR 1229, F-44000 Nantes, France

    2 shared publications
  • Gabriel Courties

    Institute of Regenerative Medicine and Biotherapy, University of Montpellier, INSERM Montpellier France

    2 shared publications
  • Julien De Lima

    Nantes Université, ONIRIS, CHU Nantes, INSERM, Regenerative Medicine and Skeleton, RMeS, Nantes, France

    2 shared publications
  • Laure-Agnès Chépeaux

    Plateforme de Cytometrie et d'Imagerie de Masse de Montpellier, Institut de Recherche en Cancerologie de Montpellier, INSERM, University of Montpellier, Institut regional du Cancer de Montpellier, Montpellier, France

    2 shared publications
  • Liliane Fossati-Jimack

    Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, and Barts NIHR Biomedical Research Centre & Barts Health NHS Trust, London, UK

    2 shared publications
  • Olivier Bortolotti

    Institute of Regenerative Medicine and Biotherapy, University of Montpellier, INSERM Montpellier France

    2 shared publications

Latest Publications

  • Top Cited Papers
    Open Access

    Spatial mapping of rheumatoid arthritis synovial niches reveals a LYVE1+ macrophage network associated with response to therapy

    by Julien De Lima, Marie-Astrid Boutet, Olivier Bortolotti, Laure-Agnès Chépeaux, Yaël Glasson, Anne-Sophie Dumé, Rachel Lau, Paul Humbert, Sophie Allain, Adrien Le Pluart, et al.


  • Open Access

    Spatial mapping of rheumatoid arthritis synovial niches reveals specific macrophage networks associated with response to therapy

    by Julien De Lima, Marie-Astrid Boutet, Olivier Bortolotti, Laure-Agnès Chépeaux, Yaël Glasson, Anne-Sophie Dumé, Adrien Le Pluart, Alessandra Nerviani, Liliane Fossati-Jimack, Henri-Alexandre Michaud, et al.

    Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease affecting peripheral joints and for which approximately 40% of the patients respond insufficiently to the available synthetic or biologic disease modifying anti-rheumatic drugs (DMARDs). The infiltration of the synovial membrane by lymphocytes and monocytes profoundly alters its homeostatic functions, leading to chronic joint inflammation and bone destruction. A better understanding of how DMARDs impact the complex synovial cell social network in relationship to response/ non-response remains an unmet need to design more targeted and active therapeutic strategies. Here, we used imaging mass cytometry (IMC) to comparatively profile more than 115,000 cells in the synovial tissue of healthy, low inflammatory osteoarthritis and matched active early treatment-naïve RA patients at baseline and at 6 months after starting DMARDs treatment. We notably highlighted that tissue resident macrophages (LYVE1 + CD206 + ) in perivascular synovial niches encompassing specific subsets of vascular cells, fibroblasts and immune cells vanished in active RA but were recovered in response to DMARDs treatment. Combined ligand-receptor analysis of single-cell RNA sequencing datasets identified that IL10, C-type lectin or TAM (TYRO3, AXL and MERTK) receptors were particularly involved in the restoration of these spatial cell interactions in the context of clinical remission. In addition to providing an unprecedented synovial spatial mapping, our work uncovered novel potential cellular and molecular targets for the development of therapies for RA. One Sentence Summary: Single-cell spatial profiling of rheumatoid arthritis synovium identifies specific cell states linked to treatment response